K-numberK242406
Device nameSiOxC Cream
ApplicantSioxmed, LLC
Product codeFRO
Device classClass U
Decision dateMar 13, 2025
DecisionSubstantially Equivalent
Regulation
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

SiOxC Cream is a non-sterile, topical skin emulsion indicated for management of pruritus and dryness associated with atopic dermatitis and allergic contact dermatitis. It is a water-based formulation containing emollients, humectants, and a proprietary amorphous hydrated silica that promotes a moist environment. The product is prescription-only and available in 1 or 8 fl oz jars.

Technological characteristics

Both the subject device and predicate (EPICERAM) are non-sterile creams that promote a moist environment as their principle of operation, applied twice daily as needed. Both use phenoxyethanol as a preservative and are biocompatible. The subject device uses a proprietary amorphous hydrated silica formulation, while the predicate uses a proprietary lipid delivery system. Available sizes differ (1 or 8 fl oz jar versus 90g tube or 225g airless pump).

Test standards cited

ISO 10993-1 (biocompatibility framework), ISO 10993-5 (in vitro cytotoxicity), ISO 10993-10 (sensitization and irritation), ISO 10993-23 (temporary contact with skin), USP <51> (preservative effectiveness testing). Human Repeat Insult Patch Test (HRIPT) was performed to assess dermal irritation and sensitization potential.

Substantial equivalence argument

The devices share the same intended use (management of dry skin in dermatitis conditions), identical principle of operation (promoting a moist environment), and similar technological characteristics including reapplication frequency, sterility status, and preservative system. Minor compositional differences (amorphous silica versus lipid delivery system) and packaging variations are addressed through biocompatibility testing and non-clinical performance data. Human testing demonstrated 100% of subjects had no visible skin reaction in both induction and challenge phases, establishing safety parity with the predicate device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →